policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
AVMA news
Organizations warn against hemp in pet food, livestock feed
Seventeen organizations sent a joint letter that encourages agriculture and state government leaders to wait for results of safety studies before…
policy
Dietary Supplement Health and Education Act of 1994
The Dietary Supplement Health and Education Act of 1994, which defines dietary supplements for use in humans, does not apply to products intended for…
JAVMA news
Assessing pet supplements
A third of all U.S. households with dogs use supplements, as do about a fifth of households with cats, according to a report on pet supplements from…
JAVMA news
In Short
Specialties proposed, ranitidine drugs contaminated, national disease list drafted
JAVMA news
Supplement companies made changes after facing crackdown
The availability of glucosamine for animals seemed to be in question 15 years ago.
JAVMA news
1935 - 1945
Information on food-producing animals was a mainstay of JAVMA during this decade.
AVMA news
FDA approves anemia drug for cats with chronic kidney disease
Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to receive…